205 related articles for article (PubMed ID: 28148532)
1. Meta-analysis of polycystic kidney disease expression profiles defines strong involvement of injury repair processes.
Malas TB; Formica C; Leonhard WN; Rao P; Granchi Z; Roos M; Peters DJ; 't Hoen PA
Am J Physiol Renal Physiol; 2017 Apr; 312(4):F806-F817. PubMed ID: 28148532
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of transcription factor profiles in polycystic kidney disease (PKD): identification and validation of STAT3 and RUNX1 in the injury/repair response and PKD progression.
Formica C; Malas T; Balog J; Verburg L; 't Hoen PAC; Peters DJM
J Mol Med (Berl); 2019 Dec; 97(12):1643-1656. PubMed ID: 31773180
[TBL] [Abstract][Full Text] [Related]
3. Metabolic reprogramming in a slowly developing orthologous model of polycystic kidney disease.
Hopp K; Kleczko EK; Gitomer BY; Chonchol M; Klawitter J; Christians U; Klawitter J
Am J Physiol Renal Physiol; 2022 Mar; 322(3):F258-F267. PubMed ID: 35037466
[TBL] [Abstract][Full Text] [Related]
4. Four-jointed knock-out delays renal failure in an ADPKD model with kidney injury.
Formica C; Happé H; Veraar KA; Vortkamp A; Scharpfenecker M; McNeill H; Peters DJ
J Pathol; 2019 Sep; 249(1):114-125. PubMed ID: 31038742
[TBL] [Abstract][Full Text] [Related]
5. Molecular pathways and therapies in autosomal-dominant polycystic kidney disease.
Saigusa T; Bell PD
Physiology (Bethesda); 2015 May; 30(3):195-207. PubMed ID: 25933820
[TBL] [Abstract][Full Text] [Related]
6. Parallel microarray profiling identifies ErbB4 as a determinant of cyst growth in ADPKD and a prognostic biomarker for disease progression.
Streets AJ; Magayr TA; Huang L; Vergoz L; Rossetti S; Simms RJ; Harris PC; Peters DJ; Ong AC
Am J Physiol Renal Physiol; 2017 Apr; 312(4):F577-F588. PubMed ID: 28077374
[TBL] [Abstract][Full Text] [Related]
7. miR-17~92 miRNA cluster promotes kidney cyst growth in polycystic kidney disease.
Patel V; Williams D; Hajarnis S; Hunter R; Pontoglio M; Somlo S; Igarashi P
Proc Natl Acad Sci U S A; 2013 Jun; 110(26):10765-70. PubMed ID: 23759744
[TBL] [Abstract][Full Text] [Related]
8. Fatty Acid Oxidation is Impaired in An Orthologous Mouse Model of Autosomal Dominant Polycystic Kidney Disease.
Menezes LF; Lin CC; Zhou F; Germino GG
EBioMedicine; 2016 Mar; 5():183-92. PubMed ID: 27077126
[TBL] [Abstract][Full Text] [Related]
9. Acute kidney injury induces hallmarks of polycystic kidney disease.
Kurbegovic A; Trudel M
Am J Physiol Renal Physiol; 2016 Oct; 311(4):F740-F751. PubMed ID: 27488998
[TBL] [Abstract][Full Text] [Related]
10. The Jeremiah Metzger Lecture. Polycystic kidney disease: old disease in a new context.
Grantham JJ
Trans Am Clin Climatol Assoc; 2002; 113():211-24; discussion 224-6. PubMed ID: 12053711
[TBL] [Abstract][Full Text] [Related]
11. Feline polycystic kidney disease mutation identified in PKD1.
Lyons LA; Biller DS; Erdman CA; Lipinski MJ; Young AE; Roe BA; Qin B; Grahn RA
J Am Soc Nephrol; 2004 Oct; 15(10):2548-55. PubMed ID: 15466259
[TBL] [Abstract][Full Text] [Related]
12. c-Myc is a regulator of the PKD1 gene and PC1-induced pathogenesis.
Parrot C; Kurbegovic A; Yao G; Couillard M; Côté O; Trudel M
Hum Mol Genet; 2019 Mar; 28(5):751-763. PubMed ID: 30388220
[TBL] [Abstract][Full Text] [Related]
13. Use of targeted sequence capture and high-throughput sequencing identifies a novel PKD1 mutation involved in adult polycystic kidney disease.
Sha YK; Sha YW; Mei LB; Huang XJ; Wang X; Lin SB; Li L; Li P
Gene; 2017 Nov; 634():1-4. PubMed ID: 28870863
[TBL] [Abstract][Full Text] [Related]
14. Generation of special autosomal dominant polycystic kidney disease iPSCs with the capability of functional kidney-like cell differentiation.
Huang J; Zhou S; Niu X; Hu B; Li Q; Zhang F; Zhang X; Cai X; Lou Y; Liu F; Xu C; Wang Y
Stem Cell Res Ther; 2017 Sep; 8(1):196. PubMed ID: 28927462
[TBL] [Abstract][Full Text] [Related]
15. Curcumin inhibits cystogenesis by simultaneous interference of multiple signaling pathways: in vivo evidence from a Pkd1-deletion model.
Leonhard WN; van der Wal A; Novalic Z; Kunnen SJ; Gansevoort RT; Breuning MH; de Heer E; Peters DJ
Am J Physiol Renal Physiol; 2011 May; 300(5):F1193-202. PubMed ID: 21345977
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of exogenous kidney-specific Ngal attenuates progressive cyst development and prolongs lifespan in a murine model of polycystic kidney disease.
Wang E; Chiou YY; Jeng WY; Lin HK; Lin HH; Chin HJ; Leo Wang CK; Yu SS; Tsai SC; Chiang CY; Cheng PH; Lin HJ; Jiang ST; Chiu ST; Hsieh-Li HM
Kidney Int; 2017 Feb; 91(2):412-422. PubMed ID: 28341240
[TBL] [Abstract][Full Text] [Related]
17. A constitutive BCL2 down-regulation aggravates the phenotype of PKD1-mutant-induced polycystic kidney disease.
Duplomb L; Droin N; Bouchot O; Thauvin-Robinet C; Bruel AL; Thevenon J; Callier P; Meurice G; Pata-Merci N; Loffroy R; Vandroux D; Costa RDA; Carmignac V; Solary E; Faivre L
Hum Mol Genet; 2017 Dec; 26(23):4680-4688. PubMed ID: 28973148
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of PKD1 causes polycystic kidney disease.
Thivierge C; Kurbegovic A; Couillard M; Guillaume R; Coté O; Trudel M
Mol Cell Biol; 2006 Feb; 26(4):1538-48. PubMed ID: 16449663
[TBL] [Abstract][Full Text] [Related]
19. Genetic Mechanisms of ADPKD.
Kim DY; Park JH
Adv Exp Med Biol; 2016; 933():13-22. PubMed ID: 27730431
[TBL] [Abstract][Full Text] [Related]
20. Periostin overexpression in collecting ducts accelerates renal cyst growth and fibrosis in polycystic kidney disease.
Raman A; Parnell SC; Zhang Y; Reif GA; Dai Y; Khanna A; Daniel E; White C; Vivian JL; Wallace DP
Am J Physiol Renal Physiol; 2018 Dec; 315(6):F1695-F1707. PubMed ID: 30332313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
